Elite Diagnostic Income Statement

Financials in millions JMD. Fiscal year is July - June.

Millions JMD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Revenue	860.95	853.82	821.28	755.33	624.22	506.91
Revenue Growth (YoY)	1.16%	3.96%	8.73%	21.00%	23.14%	15.26%
Cost of Revenue	253.81	269.69	278.13	277.27	223.58	200.5
Gross Profit	607.14	584.14	543.16	478.06	400.64	306.4
Selling, General & Admin	340.18	342.65	311.39	276.9	210.66	174.77
Operating Expenses	514.71	512.76	446.61	413.35	318.19	276.83
Operating Income	92.43	71.38	96.54	64.71	82.45	29.58
Interest Expense	-31.33	-28.24	-48.64	-32.67	-27.33	-21.02
Interest & Investment Income	0.13	0.13	0.09	0.1	0.01	0.09
Currency Exchange Gain (Loss)	2.7	2.62	-3.32	-4.56	-6.47	-6.72
Other Non Operating Income (Expenses)	-10.12	-10.9	-14.15	-14.2	-	-
EBT Excluding Unusual Items	53.81	34.99	30.53	13.39	48.66	1.93
Asset Writedown	1.93	1.93	-1.18	-	-	-
Pretax Income	55.74	36.92	29.35	13.39	48.66	1.93
Income Tax Expense	5.45	4.9	3.19	0.04	-	-
Net Income	50.29	32.02	26.16	13.35	48.66	1.93
Net Income to Common	50.29	32.02	26.16	13.35	48.66	1.93
Net Income Growth	118.40%	22.44%	95.90%	-72.56%	2422.31%	-77.44%
Shares Outstanding (Basic)	353	353	353	353	353	353
Shares Outstanding (Diluted)	353	353	353	353	353	353
EPS (Basic)	0.14	0.09	0.07	0.04	0.14	0.01
EPS (Diluted)	0.14	0.09	0.07	0.04	0.14	0.01
EPS Growth	118.40%	22.44%	95.91%	-72.56%	2422.72%	-77.45%
Free Cash Flow	105.71	167.95	92.29	-25.87	-127.87	38.8
Free Cash Flow Per Share	0.30	0.47	0.26	-0.07	-0.36	0.11
Dividend Per Share	0.010	0.010	-	-	0.020	0.090
Dividend Growth	-	-	-	-	-77.78%	-
Gross Margin	70.52%	68.41%	66.14%	63.29%	64.18%	60.45%
Operating Margin	10.74%	8.36%	11.76%	8.57%	13.21%	5.83%
Profit Margin	5.84%	3.75%	3.19%	1.77%	7.80%	0.38%
Free Cash Flow Margin	12.28%	19.67%	11.24%	-3.43%	-20.48%	7.65%
EBITDA	231.95	206.47	199.83	173.05	177.25	116.11
EBITDA Margin	26.94%	24.18%	24.33%	22.91%	28.40%	22.91%
D&A For EBITDA	139.51	135.1	103.29	108.33	94.8	86.53
EBIT	92.43	71.38	96.54	64.71	82.45	29.58
EBIT Margin	10.74%	8.36%	11.76%	8.57%	13.21%	5.83%
Effective Tax Rate	9.78%	13.27%	10.88%	0.26%	-	-
Advertising Expenses	-	3.42	5.23	9.61	5.9	4.06

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.